1. Product
Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2.
Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key Market
Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4. Voice
of Customer
5. Clinical
Trial Analysis
5.1. Ongoing Clinical
Trials
5.2. Completed Clinical
Trials
5.3. Terminated Clinical
Trials
5.4. Breakdown of
Pipeline, By Development Phase
5.5. Breakdown of
Pipeline, By Status
5.6. Breakdown of
Pipeline, By Study Application
5.7. Breakdown of
Pipeline, By Region
5.8. Clinical Trials Heat
Map
6. Global Regenerative
Wound Care Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1.
By Type (Autologous Stem Cells, Biological Skin
Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative
Wound Care Devices, Others)
6.2.2.
By Wound Type (Ulcers, Surgical & Traumatic Wounds,
Burns)
6.2.2.1.
By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
6.2.3.
By End User (Hospitals, Ambulatory Surgical Centers, Burn
Care Centers & Wound Clinics, Others)
6.2.4.
By Region
6.2.5.
By Company (2022)
6.3.
Market Map
7. North America Regenerative
Wound Care Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1.
By Type (Autologous Stem Cells, Biological Skin
Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative
Wound Care Devices, Others)
7.2.2.
By Wound Type (Ulcers, Surgical & Traumatic Wounds,
Burns)
7.2.2.1.
By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
7.2.3.
By End User (Hospitals, Ambulatory Surgical Centers, Burn
Care Centers & Wound Clinics, Others)
7.2.4.
By Country
7.3.
North America: Country Analysis
7.3.1.
United States Regenerative Wound Care Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Type
7.3.1.2.2.
By Wound Type
7.3.1.2.3.
By End User
7.3.2.
Canada Regenerative Wound Care Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Type
7.3.2.2.2.
By Wound Type
7.3.2.2.3.
By End User
7.3.3.
Mexico Regenerative Wound Care Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Type
7.3.3.2.2.
By Wound Type
7.3.3.2.3.
By End User
8. Europe Regenerative
Wound Care Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
B By Type (Autologous Stem Cells, Biological Skin
Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative
Wound Care Devices, Others)
8.2.2.
By Wound Type (Ulcers, Surgical & Traumatic Wounds,
Burns)
8.2.2.1.
By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
8.2.3.
By End User (Hospitals, Ambulatory Surgical Centers, Burn
Care Centers & Wound Clinics, Others)
8.2.4.
By Country
8.3.
Europe: Country Analysis
8.3.1.
France Regenerative Wound Care Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type
8.3.1.2.2.
By Wound Type
8.3.1.2.3.
By End User
8.3.2.
Germany Regenerative Wound Care Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type
8.3.2.2.2.
By Wound Type
8.3.2.2.3.
By End User
8.3.3.
United Kingdom Regenerative Wound Care Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type
8.3.3.2.2.
By Wound Type
8.3.3.2.3.
By End User
8.3.4.
Italy Regenerative Wound Care Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Type
8.3.4.2.2.
By Wound Type
8.3.4.2.3.
By End User
8.3.5.
Spain Regenerative Wound Care Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Type
8.3.5.2.2.
By Wound Type
8.3.5.2.3.
By End User
9. Asia-Pacific Regenerative
Wound Care Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By Type (Autologous Stem Cells, Biological Skin
Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative
Wound Care Devices, Others)
9.2.2.
By Wound Type (Ulcers, Surgical & Traumatic Wounds,
Burns)
9.2.2.1.
By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
9.2.3.
By End User (Hospitals, Ambulatory Surgical Centers, Burn
Care Centers & Wound Clinics, Others)
9.2.4.
By Country
9.3.
Asia-Pacific: Country Analysis
9.3.1.
China Regenerative Wound Care Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type
9.3.1.2.2.
By Wound Type
9.3.1.2.3.
By End User
9.3.2.
India Regenerative Wound Care Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type
9.3.2.2.2.
By Wound Type
9.3.2.2.3.
By End User
9.3.3.
Japan Regenerative Wound Care Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type
9.3.3.2.2.
By Wound Type
9.3.3.2.3.
By End User
9.3.4.
South Korea Regenerative Wound Care Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Type
9.3.4.2.2.
By Wound Type
9.3.4.2.3.
By End User
9.3.5.
Australia Regenerative Wound Care Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Type
9.3.5.2.2.
By Wound Type
9.3.5.2.3.
By End User
10. South America Regenerative
Wound Care Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Type (Autologous Stem Cells, Biological Skin
Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative
Wound Care Devices, Others)
10.2.2.
By Wound Type (Ulcers, Surgical & Traumatic Wounds,
Burns)
10.2.2.1.
By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
10.2.3.
By End User (Hospitals, Ambulatory Surgical Centers, Burn
Care Centers & Wound Clinics, Others)
10.2.4.
By Country
10.3.
South America: Country Analysis
10.3.1.
Brazil Regenerative Wound Care Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Type
10.3.1.2.2.
By Wound Type
10.3.1.2.3.
By End User
10.3.2.
Argentina Regenerative Wound Care Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Type
10.3.2.2.2.
By Wound Type
10.3.2.2.3.
By End User
10.3.3.
Colombia Regenerative Wound Care Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Type
10.3.3.2.2.
By Wound Type
10.3.3.2.3.
By End User
11. Middle East and
Africa Regenerative Wound Care Market Outlook
11.1.
Market Size & Forecast
11.1.1.
By Value
11.2.
Market Share & Forecast
11.2.1.
By Type (Autologous Stem Cells, Biological Skin
Substitutes, Tissue/Multiple Tissue Platform, Fetal Skin, Regenerative
Wound Care Devices, Others)
11.2.2.
By Wound Type (Ulcers, Surgical & Traumatic Wounds,
Burns)
11.2.2.1.
By Ulcers (Diabetic Foot Ulcers, Pressure Ulcers, Others)
11.2.3.
By End User (Hospitals, Ambulatory Surgical Centers, Burn
Care Centers & Wound Clinics, Others)
11.2.4.
By Country
11.3.
MEA: Country Analysis
11.3.1.
South Africa Regenerative Wound Care Market Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
By Type
11.3.1.2.2.
By Wound Type
11.3.1.2.3.
By End User
11.3.2.
Saudi Arabia Regenerative Wound Care Market Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
By Type
11.3.2.2.2.
By Wound Type
11.3.2.2.3.
By End User
11.3.3.
UAE Regenerative Wound Care Market Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
By Type
11.3.3.2.2.
By Wound Type
11.3.3.2.3.
By End User
12.
Market Dynamics
12.1.
Drivers
12.2.
Challenges
13.
Market Trends & Developments
13.1.
Recent Developments
13.2.
Mergers & Acquisitions
13.3.
Product Launches
14.
Competitive Landscape
14.1.
Business Overview
14.2.
Company Snapshot
14.3.
Products & Services
14.4.
Financials (As Reported)
14.5.
Recent Developments
14.6.
SWOT Analysis
14.6.1.
DeCell Technologies
Inc.
14.6.2.
Avita Medical, Inc.
14.6.3.
Organogenesis, Inc.
14.6.4.
Histogen, Inc.
14.6.5.
RenovoDerm
(Nanofiber Solutions, LLC)
14.6.6.
StemsysBio
14.6.7.
Koninklijke DSM N.V.
14.6.8.
MiMedx Group, Inc.
15. Strategic Recommendations